Reversible neurotoxicity during interleukin-2 therapy for metastatic renal cell carcinoma
Eur J Cancer
.
1995 Oct;31A(11):1895-7.
doi: 10.1016/0959-8049(95)00297-v.
Authors
J M van Laar
,
M A van Buchem
,
N Weyl
,
F J Cleton
PMID:
8541128
DOI:
10.1016/0959-8049(95)00297-v
No abstract available
Publication types
Case Reports
Letter
MeSH terms
Brain / drug effects*
Carcinoma, Renal Cell / secondary*
Female
Humans
Interleukin-2 / adverse effects*
Kidney Neoplasms / pathology*
Magnetic Resonance Imaging
Middle Aged
Ovarian Neoplasms / secondary*
Substances
Interleukin-2